Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.91 +0.72%   SPY: 135.36 +0.13%
Quote Spy SGEN NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Seattle Genetics (SGEN)

@ 4:00 PM
Click the portfolio to add SGEN:
Close [X]
+ Add SGEN to Portfolio
  
  Last Trade: $18.88 -0.13 (-0.68%)
  Volume: 870,254 65% of avg daily volume
       
  Avg Volume: 1,345,458
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 18.72 - 19.12
  Open: 19.00
  Previous Close: 19.01
  52-wk Range: 12.29 - 22.40
  Market Cap: 2.2B
  P/E: -13.0
  Div Yield: $0.00 (0.00%)
Indexes
Biotechnology Stocks (-0.7%)
Cancer Stocks (-0.9%)
Spy SGEN

? Pro holders
? Member holders
? Items submitted
Additional SGEN resources



Customize Links
To see which Pros and tickerspy members own SGEN Sign up now
Latest SGEN Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Seattle Genetics Lymphoma Drug Gets Boxed Warning on Brain Infection Risk
SGEN  
Linked by Bloomberg - January 13, 02:02PM from (www.bloomberg.com)
Seattle Genetics Inc. (SGEN) said its Hodgkin lymphoma drug Adcetris will carry a new boxed warning, the strictest U.S. caution, about a risk of dangerous brain infections.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Seattle Genetics Gains After Analyst Raises Sales Estimate for Cancer Drug
SGEN  
Linked by Bloomberg - November 28, 12:42PM from (www.bloomberg.com)
Seattle Genetics Inc. (SGEN), the maker of the recently approved cancer medicine Adcetris, rose as much as 7.9 percent after  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
24/7 Wall St. Closing Bell
ANLY  MTZ  DAL  RGLD  BIG  SBUX  IPSU  SPWR  CHK  OXGN  SGEN  DRWI  ALJ  SD  RST  TSL  LEDS  LNKD  GRPN  
Linked by 24/7 Wall St. - November 04, 04:09PM from (247wallst.com)
Markets opened lower this morning, and a modest gain of 80,000 non-farm jobs and a slight improvement of the US unemployment  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
24/7 Wall St. Top Analyst Calls of the Week
JPM  BAC  AAPL  INT  VVUS  BSX  HGSI  SLM  JNPR  SGEN  RIMM  PCLN  SQNM  NDAQ  VMW  NEM  GOOG  P  
Linked by 24/7 Wall St. - August 27, 07:31AM from (247wallst.com)
Each morning we review our top upgrades, downgrades, and initiations from Wall Street analysts. At the end of the week,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Seattle Genetics ? And Now The Hard Bit
PFE  MRK  AMGN  BIIB  SGEN  ALTH  DNDN  NVS  
Linked by Investopedia Stock Analysis - August 23, 05:00AM from (stocks.investopedia.com)
Seattle Genetics got a much-needed FDA approval, but the sales ramp could be challenging for the stock.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Seattle Genetics Shares Drop as Investors Dread Dendreon-Like Rollout
SVNT  VRTX  HGSI  SGEN  DNDN  
Linked by Bloomberg - August 22, 03:07PM from (www.bloomberg.com)
Seattle Genetics Inc. (SGEN) fell on investor concern the company’s new lymphoma medicine may meet the same sales hurdles  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Why “Sell the News” on Seattle Genetics
SGEN  
Linked by 24/7 Wall St. - August 22, 01:17PM from (247wallst.com)
There is an old rule of thumb from biotech investors and traders... SELL FDA APPROVALS. This is very counter-intuitive on  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Seattle Genetics Wins FDA Approval for Lymphoma Treatment
SGEN  
Linked by Bloomberg - August 20, 07:07PM from (www.bloomberg.com)
Seattle Genetics Inc. (SGEN) won U.S. approval to sell the first new drug for Hodgkin lymphoma in more than 30 years.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Dendreon's Bull Story In Intensive Care
JNJ  AMGN  BIIB  HGSI  SGEN  DNDN  
Linked by Investopedia Stock Analysis - August 10, 05:00AM from (stocks.investopedia.com)
Dendreon shocks bulls with a poor revenue ramp for Provenge.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Biotech news to note(8/4/11); overall market in bear mode
SPPI  VRML  ARQL  SGEN  SQNM  THLD  MNTA  PBTH  BIOD  
Linked by Chasing the Alpha - August 05, 03:21AM from (www.chasingthealpha.com)
Sorry that I have been light on blog posts recently. I've been dealing with moving into a new apartment, finishing up my  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 11



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource